Which hedge funds own SYRE? SPYRE THERAPEUTICS INC, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in SYRE (SPYRE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $235.3m in total. The largest holder by portfolio weight is Holocene Advisors at 0.2% of its book. 3 managers opened a new position this quarter: Holocene Advisors, Brevan Howard Capital Management, D. E. Shaw & Co. 1 exited: RA Capital Management.
8tracked managers holding
3opened this quarter
1exited this quarter
Which hedge funds hold SYRE? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Holocene Advisors | Q2 2026 | 0.2% | $90.1m | 1,015,170 | – | new |
| Woodline Partners | Q2 2026 | 0.1% | $27.2m | 306,049 | 15% | added |
| Marshall Wace | Q2 2026 | 0.1% | $88.0m | 991,693 | 612% | added |
| Millennium Management | Q2 2026 | 0.0% | $17.5m | 196,712 | 34% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $735.8k | 8,288 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $9.2m | 103,100 | -5% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.3m | 26,452 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $234.8k | 2,645 | -68% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| RA Capital Management | 2.6% | $81.8m |
How has hedge fund ownership of SYRE changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $235.3m |
| Q1 2026 | 6 | $115.5m |
| Q4 2025 | 4 | $83.9m |
| Q3 2025 | 1 | $2.2m |
| Q2 2025 | 2 | $7.4m |
| Q1 2025 | 2 | $9.5m |
| Q4 2024 | 2 | $14.0m |
| Q3 2024 | 3 | $13.0m |
| Q2 2024 | 5 | $32.3m |
| Q1 2024 | 5 | $30.7m |
| Q4 2023 | 2 | $4.5m |
| Q3 2023 | 2 | $2.3m |
Counts every tracked manager that disclosed SYRE in that quarter's filing, including managers that have since stopped filing.